Companies
AMD and Amazon: Two Titans Poised for Explosive Growth
Why Investors Are Doubling Down on These Market Leaders in AI and Cloud Computing Advanced Micro Devices (AMD) and Amazon...
FCC Approves $8B Paramount-Skydance Merger Amid Political Controversy
Deal includes CBS, Nickelodeon, and Paramount Pictures; DEI policies rejected as scrutiny mounts The Federal Communications Commission (FCC) on Thursday...
FAA Keeps Boeing 737 MAX Production Cap in Place Amid Ongoing Oversight
Regulator says improvements are underway but more evidence needed before raising limits The Federal Aviation Administration (FAA) has not received...
Intel Beats on Revenue, Misses on Earnings; Cuts Workforce by 15%
Chipmaker reports $12.8B in Q2 revenue, restructures amid competitive pressure and manufacturing pivot Intel (INTC) posted second-quarter results Thursday that...
Accelerant Soars in NYSE Debut, Valued at $6.4 Billion
Specialty insurance platform rides IPO wave with strong market momentum Shares of specialty insurance marketplace Accelerant (ARX) surged 35.7% in...
GoPro and Krispy Kreme Surge as Meme Stock Frenzy Reignites
Retail traders push small caps higher despite shaky fundamentals A fresh wave of meme stock mania swept through markets on...
GE Vernova Soars to Record High on Raised Cash Flow Outlook
Strong Q2 earnings and surging power demand fuel optimism despite tariff headwinds GE Vernova (GEV), the newly independent power equipment...
Earnings Season Surprises: Coca-Cola Delivers, GM Struggles Under Tariff Pressure
Positive earnings beats dominate Q2 so far, but Trump’s tariffs begin to squeeze industrial giants like GM As second-quarter earnings...
Trump Media Stock Rises After $2 Billion Bitcoin Bet
Company now holds two-thirds of its $3B in assets in crypto, embracing a bold Bitcoin treasury strategy Trump Media &...
ProMIS Neurosciences Soars 160% After FDA Fast Track Designation for Alzheimer’s Drug
PMN310 aims to deliver a safer, next-generation treatment by targeting toxic amyloid-beta in early-stage Alzheimer’s patients Shares of ProMIS Neurosciences...
